Gemifloxacin Evaluation in treating Acute bacterial Rhino-Sinusitis (GEARS study) has been conducted and expected to be published in an international journal shortly. The study proved the hypothesis that Factive has a clinical success rate of more than 90%. The study was announced in Istanbul on August 09.